Get exclusive money-saving offers and guides
Straight to your inbox
By signing up, you agree to the Finder
Privacy & Cookies Policy
and
Terms of Use, Disclaimer & Privacy Policy.
How to buy Genetic Technologies shares
Own Genetic Technologies shares in just a few minutes.
Investments
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Genetic Technologies Limited is a diagnostics & research business based in Australia. Genetic Technologies shares (GTG) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Genetic Technologies has a trailing 12-month revenue of around $25,714. If you're looking to buy shares, check out the steps below.
How to buy shares in Genetic Technologies
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Genetic Technologies . Find the share by name or ticker symbol: GTG. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Genetic Technologies reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Genetic Technologies . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
US stocks
Finder Award
Our top pick for
Cheap broker fees
Finder Award
Our top pick for
Long-term investing
Finder Award
What's in this guide?
- Genetic Technologies key stats
- Compare share trading platforms
- Is Genetic Technologies stock a buy or sell?
- Genetic Technologies performance over time
- Genetic Technologies 's financials
- How volatile are Genetic Technologies shares?
- Does Genetic Technologies pay a dividend?
- Have Genetic Technologies shares ever split?
- Other common questions
Genetic Technologies share price
Use our graph to track the performance of GTG stocks over time.Genetic Technologies shares at a glance
Information last updated 2021-06-10.
| 52-week range | $0.005 - $0.014 |
|---|---|
| 50-day moving average | $0.0085 |
| 200-day moving average | $0.009 |
| Target price | $0.25 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.002 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Genetic Technologies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Genetic Technologies price performance over time
Historical closes compared with the last close of A$0.008
| 1 week (2021-06-03) | 0.008 |
|---|---|
| 1 month (2021-05-13) | -11.11% |
| 3 months (2021-03-12) | -11.11% |
| 6 months (2020-12-11) | 0.008 |
| 1 year (2020-06-12) | 60.00% |
|---|---|
| 2 years (2019-06-13) | 23.08% |
| 3 years (2018-06-13) | -4.76% |
| 5 years (2016-06-10) | -54.80% |
Genetic Technologies financials
| Revenue TTM | $25,714 |
|---|---|
| Gross profit TTM | $-241,647 |
| Return on assets TTM | -45.42% |
| Return on equity TTM | -68.1% |
| Profit margin | 0% |
| Book value | 0.002 |
| Market capitalisation | $72.1 million |
TTM: trailing 12 months
Genetic Technologies share dividends
We're not expecting Genetic Technologies to pay a dividend over the next 12 months.
Have Genetic Technologies 's shares ever split?
Genetic Technologies 's shares were split on 28 December 1994.
Genetic Technologies share price volatility
Over the last 12 months, Genetic Technologies 's shares have ranged in value from as little as $0.005 up to $0.014. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Genetic Technologies 's is 0.8834. This would suggest that Genetic Technologies 's shares are less volatile than average (for this exchange).
Genetic Technologies overview
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company engages in the development of various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer name. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was founded in 1989 and is headquartered in Fitzroy, Australia.
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to buy Genetic Technologies shares
Steps to owning and managing Regency Centers shares.
-
How to buy The Honest Company (HNST) shares from Australia
Here's everything we know so far about The Honest Company IPO and how to buy in from Australia.
-
How to buy Genetic Technologies shares
Steps to owning and managing Applyflow shares.
-
How to buy Marqeta stock from Australia when it goes public
Here's everything we know so far about the Marqeta IPO and how to buy in from Australia.
-
How to buy Robinhood stock from Australia
Robinhood is set to go public as soon as June. Here's what you need to do to buy in from Australia.
-
How to buy Genetic Technologies shares
Steps to owning and managing Zebit shares.
-
How to buy Genetic Technologies shares
Steps to owning and managing CleanSpace shares.
-
How to buy Genetic Technologies shares
Steps to owning and managing Benz Mining shares.
-
How to buy Genetic Technologies shares
Steps to owning and managing Top Shelf International shares.
-
How to buy Genetic Technologies shares
Steps to owning and managing K12 Inc shares from Australia.
Ask an Expert
